July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
Researchers detail new findings at 2019 AACR meeting
March 28, 2019 | Zen Vuong
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.
Mothers and daughters bond, fight cancer together
November 4, 2016 | Stephanie Smith
Laura Rodriguez was just 18, just starting college, when she dropped out to help out her mother, Mary Grace, whose breast cancer had returned after 7 years. Thirty-five years later, cancer would happen again — and in some ways, history would repeat itself.
Lung cancer patient won't let disease 'steal the beauty of today'
June 23, 2016 | Stephanie Smith
A few years ago, before he was diagnosed with stage 4 lung cancer, City of Hope patient AJ Patel had a pronounced fear of cancer. Three years into targeted therapy for non small cell lung cancer he has lost that fear and found beauty from living in the moment.
Lung cancer patient finds joy in the moment
April 26, 2016 | City of Hope
Lung cancer survivor Aasit J. Patel is a man transformed. The super-friendly litigation manager from Irvine brims with life-affirming words of wisdom like, “Enjoy what you have, each and every minute!” and “Life is all about having fun!”
International women’s day: 7 women changing the world of cancer treatment
March 8, 2016 | City of Hope
At City of Hope, we’re proud to have some of the most talented and passionate women in the medical industry serving at every level of the organization. Here, we’ve spotlighted just a few of the many City of Hope physicians and scientists who are breaking exciting new ground in cancer research, treatment and care.
NCI-MATCH Trial focuses on mutations for rare cancers, not tumor site
April 15, 2015 | Nicole Levine
Precision medicine is becoming a reality for cancers with genetic mutations that are practically household names, such as those behind some breast cancers and lung cancers. A new multicenter trial focuses on providing precision treatments for rare cancers based on genetics, not tumor site.